Columbia Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Columbia Asset Management's VRTX Position: Q2 2026 in Review
Columbia Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, selling an estimated $27.9K and leaving 2,826 shares worth $1.4M. The position accounts for 0.24% of the portfolio, ranked #77.
Columbia Asset Management first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Columbia Asset Management held 2,826 shares of Vertex Pharmaceuticals worth $1.4M as of Q2 2026.
- Columbia Asset Management sold 63 Vertex Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
- Vertex Pharmaceuticals made up 0.24% of Columbia Asset Management's portfolio in Q2 2026, its #77 holding.
- Columbia Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.